☰

Lindsay Caverly - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mingora CM, Caverly LJ. Nontuberculous mycobacterial pulmonary infections in the era of elexacaftor-tezacaftor-ivacaftor. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 38307802 DOI: 10.1016/j.jcf.2024.01.010  0.31
2023 Thornton CS, Caverly LJ, Kalikin LM, Carmody LA, McClellan S, LeBar W, Sanders DB, West NE, Goss CH, Flume PA, Heltshe SL, VanDevanter DR, LiPuma JJ. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations. Annals of the American Thoracic Society. PMID 37963297 DOI: 10.1513/AnnalsATS.202306-576OC  0.362
2023 Widder S, Opron K, Carmody LA, Kalikin LM, Caverly LJ, LiPuma JJ. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis. Biorxiv : the Preprint Server For Biology. PMID 37546739 DOI: 10.1101/2023.07.21.550012  0.302
2023 Choi J, Keen EC, Wallace MA, Fishbein S, Prusa J, Zimbric M, Mejia-Chew CR, Mehta SB, Bailey TC, Caverly LJ, Burnham CD, Dantas G. Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multi-Center Cohort Reveal Parallel Signatures of In-Host Adaptation. The Journal of Infectious Diseases. PMID 37254795 DOI: 10.1093/infdis/jiad187  0.328
2022 Caverly LJ, Riquelme SA, Hisert KB. The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation. Clinics in Chest Medicine. 43: 647-665. PMID 36344072 DOI: 10.1016/j.ccm.2022.06.007  0.365
2022 Caverly LJ. Considerations for CF airway infection sampling and impact of CFTR modulators. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 36153229 DOI: 10.1016/j.jcf.2022.09.004  0.3
2022 Caverly LJ, VanDevanter DR. The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation. Journal of the Pediatric Infectious Diseases Society. 11: S40-S45. PMID 36069900 DOI: 10.1093/jpids/piac062  0.393
2022 Carmody LA, Kalikin LM, VanDevanter DR, Li G, Opron K, Simon RH, Caverly LJ, LiPuma JJ. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35667975 DOI: 10.1016/j.jcf.2022.05.011  0.303
2021 Caverly LJ, Zimbric M, Azar M, Opron K, LiPuma JJ. Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection. Erj Open Research. 7. PMID 33898611 DOI: 10.1183/23120541.00578-2020  0.389
2021 Castner LM, Zimbric M, Cahalan S, Powell C, Caverly LJ. Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 33612403 DOI: 10.1016/j.jcf.2021.02.001  0.359
2020 Filbrun AG, Enochs C, Caverly L, Rajala K, Powell C, Merrick E, Nasr SZ. Quality Improvement Initiative to Improve Pulmonary Function in Pediatric Cystic Fibrosis Patients. Pediatric Pulmonology. PMID 32770822 DOI: 10.1002/Ppul.25017  0.355
2020 Lenhart-Pendergrass PM, Caverly LJ, Wagner BD, Sagel SD, Nick JA, LiPuma JJ, Martiniano SL. Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32747193 DOI: 10.1016/j.jcf.2020.07.011  0.326
2020 Caverly L, Zimbric M, Azar M, Opron K, Lipuma J. WS18.1 Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection Journal of Cystic Fibrosis. 19. DOI: 10.1016/S1569-1993(20)30261-7  0.347
2019 Martiniano SL, Esther CR, Haworth CS, Kasperbauer SH, Zemanick ET, Caverly LJ. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis. Pediatric Pulmonology. PMID 31821718 DOI: 10.1002/ppul.24604  0.313
2019 Azar M, Zimbric M, Shedden K, Caverly LJ. Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31399327 DOI: 10.1016/J.Jcf.2019.07.007  0.323
2019 Nasr S, Filbrun A, Enochs C, Caverly L, Stiffler J, Vess T, Rajala K, Lehrmann J, Iwanicki C, Bouma S, Tales K, Tapley C, Fenner B. P191 Quality improvement project to improve pulmonary function in paediatric cystic fibrosis patients Journal of Cystic Fibrosis. 18. DOI: 10.1016/S1569-1993(19)30485-0  0.329
2018 Caverly LJ, LiPuma JJ. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice. Expert Review of Respiratory Medicine. 12: 857-865. PMID 30118374 DOI: 10.1080/17476348.2018.1513331  0.345
2018 Carmody LA, Caverly LJ, Foster BK, Rogers MAM, Kalikin LM, Simon RH, VanDevanter DR, LiPuma JJ. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis. Plos One. 13: e0194060. PMID 29522532 DOI: 10.1371/journal.pone.0194060  0.303
2014 Ramirez IA, Caverly LL, Kalikin LM, Goldsmith AM, Lewis TC, Burke DT, LiPuma JJ, Sajjan US, Hershenson MB. Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis. Annals of the American Thoracic Society. 11: 554-61. PMID 24641803 DOI: 10.1513/Annalsats.201310-346Oc  0.355
Show low-probability matches.